Paraneoplastic dermatomyositis associated with urothelial cancer: report of a case and systematic review of the literature

Paraneoplastic dermatomyositis associated with urothelial cancer: report of a case and systematic review of the literature

BackgroundThe idiopathic inflammatory myopathies (IIM) are a collection of autoimmune diseases that have a substantial impact on the entire body and include conditions such as dermatomyositis (DM), polymyositis (PM), sporadic inclusion body myositis, and immune-mediated necrotizing myopathy. These d...

Full description

Bibliographic Details
Main Authors:	Josep Sabaté-Ortega, Elisabet Bujons-Buscarons, Clàudia Fina-Planas, Núria Vilanova-Anducas, Noemí Vidal-Sarró, Núria Sala-González
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Oncology
Subjects:	bladder cancer polymyositis dermatomyositis urothelial cancer dermato/polymyositis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1223627/full

Similar Items

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
by: Shimojima Yasuhiro, et al.
Published: (2012-11-01)

Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
by: Marilda Guimarães Silva, et al.
Published: (2018-02-01)

Malignancy in a retrospective cohort of 17 patients with Dermatomyositis or Polymyositis in southern Tunisia
by: Sellami Khadija, et al.
Published: (2018-12-01)

Ascending Colon Cancer Associated with Dermatomyositis Which Was Cured after Colon Resection
by: Hirohiko Kamiyama, et al.
Published: (2016-06-01)

Muscle biopsies in dermatomyositis and polymyositis: practical relevance of analyzing different levels of histological sections of the same muscular compartment
by: Monica T. M. Diaz, et al.
Published: (2017-06-01)

Polymyositis and dermatomyositis: Disease spectrum and classification
by: Siba P Raychaudhuri, et al.
Published: (2012-01-01)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
by: Takuya Hirai, et al.
Published: (2018-01-01)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
by: mei liu, et al.
Published: (2023-11-01)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)

Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach
by: Ha-Neul Jeong, et al.
Published: (2023-12-01)

Pyomyositis Secondary to Localized Cellulitis in a Dermatomyositis Patient: A Case Report and Review of Infectious Complications in Dermatomyositis
by: Zhang X, et al.
Published: (2023-08-01)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.
by: Agnieszka Trybuch, et al.
Published: (2023-07-01)

Subcutaneous Emphysema, Pneumomediastinum and Pneumothorax in a Patient with Dermatomyositis
by: Mehdi Bakhsaee, et al.
Published: (2017-03-01)

Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
by: Juyoung Yoo, et al.
Published: (2021-03-01)

18F-FDG PET/CT in patients with polymyositis/dermatomyositis: correlation with serum muscle enzymes
by: Hanae Arai-Okuda, et al.
Published: (2020-08-01)

Clinical Characteristics and Associated Factors for Infection and in-Hospital Mortality in Inpatients with Polymyositis/Dermatomyositis in China: A Retrospective Study
by: Lao M, et al.
Published: (2023-01-01)

A Rare Case of Sporadic Inclusion Body Myositis (s-IBM)
by: Sourya Acharya, et al.
Published: (2016-01-01)

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
by: Tao Liu, et al.
Published: (2017-01-01)

KL-6 in adult polymyositis and dermatomyositis patients and its correlation with interstitial lung disease
by: Mayada Khalil, et al.
Published: (2023-12-01)

Prevalence of hearing loss, tinnitus, vertigo and sudden deafness among patients with polymyositis and dermatomyositis
by: Shih-Han Hung, et al.
Published: (2024-03-01)

Involvement of YKL-40-positive macrophages commonly identified in polymyositis and dermatomyositis in the pathogenesis of myositis: a retrospective study
by: Kazuteru Noguchi, et al.
Published: (2024-01-01)

Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis
by: Zoltan Griger, et al.
Published: (2020-09-01)

Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study
by: Jang Woo Ha, et al.
Published: (2023-10-01)

The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature
by: S. Barsotti, et al.
Published: (2018-07-01)

Physical exercise among patients with systemic autoimmune myopathies
by: Diego Sales de Oliveira, et al.
Published: (2018-05-01)

Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
by: Fernando Henrique Carlos de Souza, et al.
Published: (2018-09-01)

Exploring Road of Classification Criteria for Idiopathic Inflammatory Myopathy
by: Yu-Hui Li, et al.
Published: (2018-01-01)

Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis
by: Joan Raouf, et al.
Published: (2018-05-01)

Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis
by: O A Antelava, et al.
Published: (2014-05-01)

Subclinical systolic and diastolic myocardial dysfunction in polyphasic polymyositis/dermatomyositis: a 2-year longitudinal study
by: Andrea Péter, et al.
Published: (2022-09-01)

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab
by: Knight T, et al.
Published: (2017-05-01)

Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis
by: Sung Soo Ahn, et al.
Published: (2022-04-01)

Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis
by: Li Y, et al.
Published: (2018-01-01)

Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies
by: Michael Mahler, et al.
Published: (2021-11-01)

Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array
by: Ai Kuzumi, et al.
Published: (2023-08-01)

Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review
by: A. Camargo-Coronel, et al.
Published: (2023-05-01)

Study on advances in the association between autoantibodies and clinical phenotypes in idiopathic inflammatory myopathy
by: ZHANG Hao, CHI Huihui, SU Yutong, YANG Chengde
Published: (2022-06-01)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
by: Stefano Palmucci, et al.
Published: (2022-11-01)

Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study
by: Yaogui Ning, et al.
Published: (2019-11-01)

Inflammatory Bowel Diseases Are Associated with Polymyositis and Dermatomyositis—A Retrospective Cohort Analysis
by: Kassem Sharif, et al.
Published: (2022-11-01)